Hrt Financial LP Alx Oncology Holdings Inc Transaction History

Hrt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$10.95 - $16.79 $648,086 - $993,732	59,186 New	59,186 $659,000
Q2 2023 Aug 11, 2023	SELL	$4.37 - $9.56 $250,702 - $548,447	-57,369 Reduced 69.5%	25,176 $189,000
Q1 2023 May 12, 2023	BUY	$4.52 - $11.71 $373,103 - $966,601	82,545 New	82,545 $373,000
Q2 2022 Aug 12, 2022	BUY	$5.89 - $19.46 $509,308 - $1.68 Million	86,470 New	86,470 $699,000
Q3 2021 Nov 15, 2021	SELL	$52.51 - $80.91 $346,040 - $533,196	-6,590 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$52.2 - $75.23 $343,998 - $495,765	6,590 New	6,590 $360,000

101

39.7M

134K

17.4K

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $68.9M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.